Cargando…
Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US
INTRODUCTION: Participation in early-phase HIV cure studies includes clinical risks with little to no likelihood of clinical benefit. Examining the willingness of people living with HIV to participate is important to guide study design and informed consent. Our study examined the overall willingness...
Autores principales: | Dubé, Karine, Evans, David, Sylla, Laurie, Taylor, Jeff, Weiner, Bryan J, Skinner, Asheley, Thirumurthy, Harsha, Tucker, Joseph D, Rennie, Stuart, Greene, Sandra B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337420/ https://www.ncbi.nlm.nih.gov/pubmed/28275457 |
Ejemplares similares
-
'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States
por: Dubé, Karine, et al.
Publicado: (2017) -
Research on HIV cure: Mapping the ethics landscape
por: Dubé, Karine, et al.
Publicado: (2017) -
Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research
por: Dubé, Karine, et al.
Publicado: (2015) -
Willingness to participate in HIV research at the end of life (EOL)
por: Prakash, Katya, et al.
Publicado: (2018) -
Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
por: Dubé, Karine, et al.
Publicado: (2020)